Drug Shortage Report for PROLEUKIN
Report ID | 235968 |
Drug Identification Number | 02130181 |
Brand name | PROLEUKIN |
Common or Proper name | PROLEUKIN |
Company Name | IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC |
Market Status | MARKETED |
Active Ingredient(s) | ALDESLEUKIN |
Strength(s) | 22000000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 VIAL |
ATC code | L03AC |
ATC description | IMMUNOSTIMULANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2024-09-13 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-08-21 |
Company comments | Imported product is available to meet demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 CRESCENT DRIVE, SUITE 303 PHILADELPHIA, PENNSYLVANIA UNITED STATES 19112 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.